Investors: Meet Dr. Peter Fischer at LSI Europe ’25
- Aug 25, 2025
- 1 min read
Dr. Peter Fischer, CEO of InkSpace Imaging, will present on Stage 1 at LSI Europe ’25 on Monday, September 8, 2025 at 2:40 PM.
📅Session snapshot
Event: LSI Europe 2025
When: Monday, September 8, 2025
Time: 2:40 PM (Stage 1)
Speaker: Dr. Peter Fischer, CEO, InkSpace Imaging
The investment thesis (at a glance)
Market size: Competing in a $2B+ MRI coil market with clear replacement demand.
Clinical pain point: Legacy coils are heavy, rigid, and contribute to motion, sedation, and repeat scans.
Our approach: Next-gen, 24-channel coils with an ultra-light, body-conforming design that fits existing workflows.
Value drivers for hospitals: Fewer repeats, less sedation, faster throughput, improved image quality, better patient experience.
Defensibility: Product design, data and workflow advantages, and an IP position designed to protect share.
Commercial path: Focused use cases, a capital-efficient rollout, and partnerships that accelerate site adoption.
Milestones: Clear near-term catalysts that de-risk scale and move valuation.
Why now
Hospitals are pushing past the limits of legacy coil hardware. Budgets are shifting toward solutions that improve image quality and throughput while reducing operational friction. With demand rising for lighter, more comfortable coils that drop into current workflows, timing for this category is strong.
What you’ll learn
Where InkSpace Imaging wins in the MRI suite and how that maps to budget priorities for human and animal health.
How our 24-channel, body-conforming coils change scan quality, speed, and patient comfort
The commercialization plan, including channels, pricing logic, and site payback
The next 3–4 milestones that unlock scale and value creation
Let’s connect at LSI Europe
If you’re attending and want the investor brief or to schedule a 1:1, send an email here.
See you on Stage 1 at 2:40 PM, September 8.
